AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2025
May 8, 2025
30339_dirs_2025-05-08_ed12a0b8-b2f5-4260-a40a-d3c471308fd9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2025-05-06
Reporting Person: Lockhart Stephen H (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-06 | Common Stock | A | 1071 | — | Acquired | 2708.407 | Direct |
Footnotes
F1: These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting.
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27